UNITED STATES
                        SECURITIES & EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                  SCHEDULE 13D

                    Under the Securities Exchange Act of 1934
                              (Amendment No.___ )*

                               Moore Medical Corp.
                                (Name of Issuer)

                                    615799103
                                  Common Stock
                         (Title of Class of Securities)


                                 (CUSIP Number)

                              Michael Emanuel, Esq.
                          c/o Loeb Partners Corporation
                  61 Broadway, N.Y., N.Y., 10006 (212) 483-7047
          (Name, address and Telephone Number of Person Authorized to
                        Receive Notices and Communications)

                                February 5, 2003
             (Date of Event which Requires Filing of this Statement)

If the filing person has previously  filed a statement on Schedule 13G to report
the  acquisition  which is the subject of this  Schedule 13D, and is filing this
schedule  because of Rule 13d-1(b)(3) or (4), check the following box [ ]. Check
the  following  box if a fee is being  paid  with  statement  [ ]. (A fee is not
required only if the following reporting person: (1) has a previous statement on
file  reporting  beneficial  ownership of more than five percent of the class of
securities  described  is Item 1;  and (2) has  filed  no  amendment  subsequent
thereto reporting  beneficial  ownership of five percent or less of such class.)
(See Rule 13d-7.) Note:  Six copies of this  statement,  including all exhibits,
should be filed with the Commission. See Rule 13d-1(a) for other parties to whom
copies are to be sent. *The remainder of this cover page shall be filled out for
a reporting  person's  initial  filing on this form with  respect to the subject
class of securities,  and for any subsequent  amendment  containing  information
which would alter  disclosures  provided in a prior cover page. The  information
required  on the  remained  of this cover page shall not be deemed to be "filed"
for the purpose of Section 18 of the Securities  Exchange Act of 1934 ("Act") or
otherwise  subject to the  liabilities  of that  section of the Act but shall be
subject to all other provisions of the Act (however, see the Notes).



                                  SCHEDULE 13D

CUSIP NO. 615799103

1  NAME OF REPORTING PERSON
    S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

          Loeb Partners Corporation

2  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*          (a) [X]

                                                              (b) [ ]
3  SEC USE ONLY
4  SOURCE OF FUNDS*

         WC, O

5  CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED     [    ]
    PURSUANT TO ITEMS 2(d) or 2(e)

6  CITIZENSHIP OR PLACE OF ORGANIZATION
         Delaware

NUMBER OF         7  SOLE VOTING POWER
SHARES               11,135 Shares of Common stock
BENEFICIALLY      8  SHARED VOTING POWER
OWNED BY              7,239 Shares of Common stock
EACH              9  SOLE DISPOSITIVE POWER
REPORTING            11,135 Shares of Common stock
PERSON WITH      10  SHARED DISPOSITIVE POWER
                      7,239 Shares of Common stock

11  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

          18,374 Shares of Common stock

12  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN  SHARES*

13  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
         0.58%

14 TYPE OF REPORTING PERSON*
         PN, BD, IA


                                  SCHEDULE 13D
CUSIP NO. 615799103

1  NAME OF REPORTING PERSON
   S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

          Loeb Arbitrage Fund

2  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*          (a) [X]

                                                              (b) [ ]
3  SEC USE ONLY

4  SOURCE OF FUNDS

         WC, O

5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED            [  ]
     PURSUANT TO ITEMS 2(d) or 2(e)

6  CITIZENSHIP OR PLACE OF ORGANIZATION

         New York

NUMBER OF         7  SOLE VOTING POWER
SHARES               187,064 Shares of Common stock
BENEFICIALLY      8  SHARED VOTING POWER
OWNED BY                   -----
EACH              9  SOLE DISPOSITIVE POWER
REPORTING            187,064 Shares of Common stock
PERSON WITH      10  SHARED DISPOSITIVE POWER
                           -----

11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
            187,064 Shares of Common stock

12  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

13  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
           5.85%

14 TYPE OF REPORTING PERSON*
           PN, BD


                                  SCHEDULE 13D

CUSIP NO. 615799103

1  NAME OF REPORTING PERSON
    S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

          Loeb Offshore Fund, Ltd.

2  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*          (a) [X]

                                                              (b) [ ]
3  SEC USE ONLY

4  SOURCE OF FUNDS*

         WC, O

5  CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED     [    ]
    PURSUANT TO ITEMS 2(d) or 2(e)

6  CITIZENSHIP OR PLACE OF ORGANIZATION
         Cayman Islands

NUMBER OF         7  SOLE VOTING POWER
SHARES               17,262 Shares of Common stock
BENEFICIALLY      8  SHARED VOTING POWER
OWNED BY                 --------
EACH              9  SOLE DISPOSITIVE POWER
REPORTING            17,262 Shares of Common stock
PERSON WITH      10  SHARED DISPOSITIVE POWER
                          -------

11  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

          17,262 Shares of Common stock

12  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN  SHARES*

13  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
         0.54%

14 TYPE OF REPORTING PERSON*
         CO

Item 1.  Security and Issuer.
------   -------------------

This  statement  refers to the Common  Stock of Moore  Medical  Corp., 389 John
Downey Drive, P.O. Box 1500, New Britain, CT., 06050.

Item 2.  Identity and Background.
------   -----------------------

Loeb Arbitrage Fund ("LAF"),  61 Broadway,  New York, New York,  10006, is a New
York limited partnership. It is a registered broker/dealer.  Its general partner
is Loeb Arbitrage Management,  Inc., ("LAM"), a Delaware  corporation,  with the
same  address.  Its President is Gideon J. King.  The other  officers of LAM are
Thomas L. Kempner, Chairman of the Board, President, Peter A. Tcherepnine,  Vice
President,  Edward  J.  Campbell,  Vice  President.  Loeb  Partners  Corporation
("LPC"), 61 Broadway,  New York, New York, 10006, is a Delaware corporation.  It
is a registered  broker/dealer and a registered  investment  adviser.  Thomas L.
Kempner is its President and a director and its Chief Executive Officer.  Norman
N. Mintz is a Vice  President  and also a director.  Gideon J. King is Executive
Vice President.  Loeb Holding Corporation  ("LHC"), a Maryland  corporation,  61
Broadway,  New York,  New York,  10006 is the sole  stockholder  of LAM and LPC.
Thomas L. Kempner is its President and a director as well as its Chief Executive
Officer and majority stockholder.  Edward E. Matthews, Norman N. Mintz and Peter
A. Tcherepnine are also directors.  Mr. Matthews' address is 70 Pine Street, New
York,  New York 10270.  Loeb Offshore  Fund,  Ltd.,  ("LOF") is a Cayman Islands
exempted company.  Loeb Offshore  Management,  LLC ("LOM") is a Delaware limited
liability company,  a registered  investment adviser and is wholly owned by Loeb
Holding  Corporation.  It is the investment  adviser of LOF.  Gideon J. King and
Thomas L. Kempner are Directors of LOF and Managers of LOM. The business address
of all individuals  other than Mr. Matthews is 61 Broadway,  New York, New York,
10006. All of the individuals named are United States citizens.  None have been,
within  the last five  years,  convicted  in a  criminal  proceeding  (excluding
traffic  violations  or  similar  misdemeanors)  or  been  a  party  to a  civil
proceeding of a judicial or administrative body of competent jurisdiction and as
a result of such proceeding  been or are subject to a judgment,  decree or final
order  enjoining  future  violations of, or prohibiting or mandating  activities
subject to,  federal or state  securities  laws or finding any  violations  with
respect to such laws.

Item 3.   Source and Amount of Funds or Other Compensation.
------    ------------------------------------------------

Shares of Common  Stock were  acquired  by LAF,  LPC and LOF in margin accounts
maintained with Bear Stearns Securities Corp.

Item 4.   Purpose of Transaction.
------    ----------------------

LAF, LPC and LOF have acquired  shares of Common Stock for investment  purposes.
LAF,  LPC and LOF reserve the right to sell shares of Common Stock or to acquire
additional shares in open market transactions or otherwise.


Item 5.  Interest in Securities of the Issuer.
------   ------------------------------------

(a) The persons reporting hereby owned the following shares of
Common Stock as of Februay 5, 2004.

                                     Shares of Common Stock

Loeb Arbitrage Fund                        187,064
Loeb Partners Corporation*                  18,374
Loeb Offshore Fund                          17,262
                                    --------------
                                           222,700

The total shares of Common Stock constitute 6.96% the 3,200,009 outstanding
shares of Common Stock as reported by the issuer.
-------------------------
*Including 7,239 shares of Common Stock purchased for the account of one
customer of Loeb Partners Corporation as to which it has investment discretion.

(b) See paragraph (a) above.

(c) The following purchases of Common Stock have been made in the last sixty
(60) days by the following:

                                   Purchases of Common Stock

Holder                            Date     Shares      Average Price
Loeb Partners Corp.*          01-22-04        479             $13.52
                              01-23-04       2138              14.74
                              01-23-04       3266              14.74
                              01-28-04        899              14.73
                              01-29-04       2063              14.73
                              02-03-04        639              14.65
                              02-03-04        640              14.64
                              02-04-04       1650              14.67
                              02-05-04       2475              14.53
                              02-05-04       4125              14.53


Holder                                     Shares      Average Price
Loeb Arbitrage Fund           01-22-04       4871             13.523
                              01-23-04        420             14.723
                              01-23-04      54599             14.742
                              01-28-04       9156             14.733
                              01-29-04      20999             14.733
                              02-03-04       6468             14.663
                              02-03-04       6551             14.626
                              02-04-04      16800             14.673
                              02-05-04      25200             14.528
                              02-05-04      42000             14.525


Holder                                     Shares      Average Price
Loeb Offshore Fund            01-22-04        450              13.52
                              01-23-04         39              14.74
                              01-23-04       5038              14.74
                              01-28-04        845              14.73
                              01-29-04       1938              14.73
                              02-03-04        605              14.65
                              02-03-04        597              14.64
                              02-04-04       1550              14.67
                              02-05-04       2325              14.53
                              02-05-04       3875              14.53



--------------------
*Including 7,239 Shares of Common Stock purchased for the account of one
customer of Loeb Partners Corporation as to which it has investment discretion.

All reported transactions were effected on the American Stock Exchange.

(d) Not applicable.

(e). Not applicable.

Item 6.Contracts, Arrangements, Understandings or Relationships with Respect to
       the Issuer.

                  None.

Item 7.  Materials to be Filed as Exhibits.

                  None.
Signature

After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.

February 6, 2004                  Loeb Partners Corporation


                        By: /s/ Gideon J. King, Executive Vice President


February 6, 2004                   Loeb Arbitrage Fund
                        By: Loeb Arbitrage Management, Inc.


                        By: /s/ Gideon J. King, President

February 6, 2004                   Loeb Offshore Fund


                        By: /s/ Gideon J. King, Director